High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: Dosimetric analysis and clinical outcome

International Journal of Radiation Oncology Biology Physics

Volumn 87, Issue 5, 2013, Pages 1086-1093

  Bi, Xi Wen ^a   Li, Ye Xiong ^a   Fang, Hui ^a   Jin, Jing ^a   Wang, Wei Hu ^a   Wang, Shu Lian ^a   Liu, Yue Ping ^a   Song, Yong Wen ^a   Ren, Hua ^a   Dai, Jian Rong ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CERVICAL LYMPH NODES; DOSIMETRIC PARAMETER; INTENSITY-MODULATED RADIATION THERAPY; LOCOREGIONAL CONTROL; LOCOREGIONAL CONTROL RATE; METHODS AND MATERIALS; PLANNING TARGET VOLUMES; PROGRESSION FREE SURVIVAL;

DOSIMETRY; ONCOLOGY; PHYSICAL THERAPY; RADIOTHERAPY;

TOXICITY;

ASPARAGINASE; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE TOXICITY; ADOLESCENT; ADULT; ANEMIA; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CHILD; CHRONIC TOXICITY; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; DYSGEUSIA; DYSPHAGIA; FEMALE; FEVER; HEAD AND NECK CANCER; HOARSENESS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LEUKOPENIA; LYMPHOID TISSUE; MALE; MUCOSA INFLAMMATION; NASOPHARYNX CANCER; NATURAL KILLER T CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CANCER; OVERALL SURVIVAL; PAROTID GLAND; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RETROSPECTIVE STUDY; T CELL LYMPHOMA; TARGET ORGAN; THROMBOCYTOPENIA; TONGUE CANCER; TONSIL CANCER; TREATMENT OUTCOME; TREATMENT PLANNING; WALDEYER RING; XEROSTOMIA; COMPUTER ASSISTED RADIOTHERAPY; CONSERVATIVE TREATMENT; DISEASE FREE SURVIVAL; LYMPHOMA, EXTRANODAL NK-T-CELL; MIDDLE AGED; MORTALITY; NASOPHARYNGEAL NEOPLASMS; NECK; NOSE NEOPLASMS; ORGANS AT RISK; OROPHARYNGEAL NEOPLASMS; PATHOLOGY; PHARYNGEAL NEOPLASMS; PROCEDURES; RADIATION RESPONSE; RADIOGRAPHY; RADIOTHERAPY; TUMOR INVASION; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC IRRADIATION; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NECK; NEOPLASM INVASIVENESS; NOSE NEOPLASMS; ORGAN SPARING TREATMENTS; ORGANS AT RISK; OROPHARYNGEAL NEOPLASMS; PAROTID GLAND; PHARYNGEAL NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; XEROSTOMIA; YOUNG ADULT;

EID: 84888307031     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.08.040     Document Type: Article

References (35)

1. W.Y. Au, D.D. Weisenburger, and T. Intragumtornchai Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project Blood 113 2009 3931 3937
2. T.M. Kim, S.Y. Lee, and Y.K. Jeon Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group Ann Oncol 19 2008 1477 1484
3. J. Lee, C. Suh, and Y.H. Park Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study J Clin Oncol 24 2006 612 618
4. Y.X. Li, B. Yao, and J. Jin Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma J Clin Oncol 24 2006 181 189
5. J.C. Jo, D.H. Yoon, and S. Kim Clinical features and prognostic model for extranasal NK/T-cell lymphoma Eur J Haematol 89 2012 103 110
6. Y.X. Li, Q.F. Liu, and H. Fang Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma Clin Cancer Res 15 2009 2905 2912
7. M.M. Cheung, J.K. Chan, and W.H. Lau Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality Int J Radiat Oncol Biol Phys 54 2002 182 190
8. Y.X. Li, P.A. Coucke, and J.Y. Li Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy Cancer 83 1998 449 456
9. Y.X. Li, H. Fang, and Q.F. Liu Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring Blood 112 2008 3057 3064
10. M.J. Huang, Y. Jiang, and W.P. Liu Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract Int J Radiat Oncol Biol Phys 70 2008 166 174
11. J.Y. You, K.H. Chi, and M.H. Yang Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan Ann Oncol 15 2004 618 625
12. Y.X. Li, H. Wang, and J. Jin Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK/T-cell lymphoma Int J Radiat Oncol Biol Phys 82 2012 1809 1815
13. Z.Y. Wang, Q.F. Liu, and H. Wang Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy Blood 120 2012 2003 2010
14. M.K. Kam, P.M. Teo, and R.M. Chau Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience Int J Radiat Oncol Biol Phys 60 2004 1440 1450
15. G. Peng, T. Wang, and K.Y. Yang A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma Radiother Oncol 104 2012 286 293
16. J. Setton, N. Caria, and J. Romanyshyn Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience Int J Radiat Oncol Biol Phys 82 2012 291 298
17. W.L. Kuang, Q. Zhou, and L.F. Shen Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma Clin Transl Oncol 14 2012 783 790
18. H. Wang, Y.X. Li, and W.H. Wang Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK/T-cell lymphoma Int J Radiat Oncol Biol Phys 82 2012 1115 1121
19. G.E. Kim, S.W. Lee, and S.K. Chang Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck Radiother Oncol 61 2001 261 269
20. I.I. Na, H.J. Kang, and Y.H. Park Prognostic factors for classifying extranodal NK/T cell lymphoma, nasal type, as lymphoid neoplasia Eur J Haematol 79 2007 1 7
21. J.K.C. Chan, L. Quintanilla-Martinez, and J.A. Ferry Extranodal NK/T-cell lymphoma, nasal type E.S. Jaffe, N.L. Harris, H. Stein, World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues 8th ed. 2008 IARC Press Lyon, France 285 288
22. P.P. Carbone, H.S. Kaplan, and K. Mushoff Report of the committee on Hodgkin's disease staging classification Cancer Res 31 1971 1860 1861
23. I. Paddick A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note J Neurosurg 93 Suppl 3 2000 219 222
24. B.D. Cheson, S.J. Horning, and B. Coiffier Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group J Clin Oncol 17 1999 1244 1253
25. A. Trotti, A.D. Colevas, and A. Setser CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181
26. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
27. K.S. Chao, N. Majhail, and C.J. Huang Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques Radiother Oncol 61 2001 275 280
28. M.K. Kam, S.F. Leung, and B. Zee Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients J Clin Oncol 25 2007 4873 4879
29. I. Poon, P. Xia, and V. Weinberg A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 69 2007 1625 1633
30. S.H. Lu, J.C. Cheng, and S.H. Kuo Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT Radiother Oncol 104 2012 324 330
31. 18F-FDG-PET-guided dose escalation in oropharyngeal cancer: a planning study Med Dosim 38 2013 18 24
32. A.I. Blanco, K.S. Chao, and I. El Naqa Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy Int J Radiat Oncol Biol Phys 62 2005 1055 1069
33. L. Saleh-Ebrahimi, F. Zwicker, and M.W. Muenter Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer - a retrospective single center analysis Radiat Oncol 8 2013 20
34. N. Lee, P. Xia, and N.J. Fischbein Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation Int J Radiat Oncol Biol Phys 57 2003 49 60
35. Y.L. Kwong, W.S. Kim, and S.T. Lim SMILE for natural killer (NK)/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group Blood 120 2012 2973 2980